| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
14,253 |
5,735 |
$591K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
7,145 |
3,139 |
$267K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
8,205 |
3,133 |
$100K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
686 |
497 |
$19K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
234 |
214 |
$10K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,071 |
700 |
$6K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
477 |
419 |
$6K |
| 87581 |
|
453 |
415 |
$2K |
| 87631 |
|
234 |
215 |
$2K |
| 87541 |
|
455 |
417 |
$2K |
| 87486 |
|
455 |
417 |
$2K |
| 87640 |
|
455 |
417 |
$2K |
| 87496 |
|
121 |
116 |
$270.11 |
| 87498 |
|
121 |
116 |
$210.53 |